English  |  正體中文  |  简体中文  |  2832348  
???header.visitor??? :  33736004    ???header.onlineuser??? :  1414
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"ochoa de olza m"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:08:59Z A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors Naing A.; Gainor J.F.; Gelderblom H.; Forde P.M.; Butler M.O.; Chia-Chi Lin; Sharma S.; Ochoa De Olza M.; Varga A.; Taylor M.; Schellens J.H.M.; Wu H.; Sun H.; Silva A.P.; Faris J.; Mataraza J.; Cameron S.; Bauer T.M.
臺大學術典藏 2020-05-25T07:35:09Z Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer Chia-Chi Lin; Taylor M; Boni V; Brunsvig P.F; Geater S.L; Salvagni S; Garrido Lopez P; ?zg?ro?lu M; Sriuranpong V; Ponce Aix S; Ascierto P.A; Fasolo A; Sezer A; Kowalski D.M; Faris J.E; Cameron S; Mataraza J; Wu H; Antona V; Ochoa de Olza M.
臺大學術典藏 2020-05-25T07:35:01Z A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors Naing A; Gainor J.F; Gelderblom H; Forde P.M; Butler M.O; Chia-Chi Lin; Sharma S; Ochoa De Olza M; Varga A; Taylor M; Schellens J.H.M; Wu H; Sun H; Silva A.P; Faris J; Mataraza J; Cameron S; Bauer T.M.

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page